1 / 35

Introduction - Toxoplasma gondii

Introduction - Toxoplasma gondii. Obligate intracellular parasite Infects a wide range of avian and mammalian species Host: cat; can be carried by mammals and birds Can cause severe disease in humans Toxoplasmosis can have fatal effects on a fetus

davin
Download Presentation

Introduction - Toxoplasma gondii

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Introduction - Toxoplasma gondii • Obligate intracellular parasite • Infects a wide range of avian and mammalian species • Host: cat; can be carried by mammals and birds • Can cause severe disease in humans • Toxoplasmosis can have fatal effects on a fetus • T. gondii can exist as either rapidly growing tachyzoites or bradyzoites that reside in semidormant cysts

  2. Introduction - Toxoplasma gondii • NK cells, CD4+ T cells and CD8+ T cells produce cytokines against T. gondii • CD8+ T cells are known to have a critical protective function • Resistance to toxoplasmic encephalitis in H-2d mice has been linked to the locus encoding H-2Ld MHC class I • The mechanisms and antigens that elicit the activation and expansion of T. gondii–specific CD8+ T cell populations are not understood

  3. Introduction - Antigen processing • CD8+ T cells recognize intracellular protein derived peptides presented by MHC class I • Antigenic peptides: proteolysis in the cytoplasm, transport into the ER, further processing by the aminopeptidase ERAAP • ERAAP is very important for shaping of peptides for MHC class I

  4. Clinical and Experimental Immunology 2005 TCR: T cell receptor; TAP: transporter associated with antigen processing; ERAAP: endoplasmic reticulum aminopeptidase associated with antigen processing

  5. Questions What are the natural antigens for MHC class I presentation and how are they processed?

  6. Infection of ERAAP-deficient mice • i.p. infection of resistant H-2d mice (B10.D2) with T. gondii tachyzoites • ERAAP deficient • ERAAP-heterozygous • wild-type Tachyzoites: rapidly growing T. gondii; ERAAP: endoplasmic reticulum aminopeptidase associated with antigen processing

  7. ERAAP-deficient mice are susceptible to T. gondii Flow cytometry – heterozygous/wt – deficient PCR  Survival was significantly impaired in the absence of ERAAP ERAAP: endoplasmic reticulum aminopeptidase associated with antigen processing

  8. T. gondii hybridomas • Immunization of resistant BALB/c (H-2d) mice with γ-irradiated tachyzoites • CD8+ T cells and CD4+ T cells produced IFN-γ • Expansion of the T. gondii–specific CD8+ T cell populations by restimulation in vitro Tachyzoites: rapidly growing T. gondii

  9. T. gondii hybridomas • Hybridoma were created by fusion of the T. gondii–specific CD8+ T cells and a TCR αβ-negative fusion partner with inducible β-galactosidase • Occupancy of the TCR can be assayed by measurement of intracellular lacZ activity • T. gondii infection of APCs expressing H-2Ld or H-2Kd MHC class I molecules

  10. T. gondii hybridomas • Response of the hybridomas to T. gondii infected APCs expressing H-2Ld but not to those expressing H-2Kd MHC class I molecules • H-2Ld and a T. gondii-derivedpeptide is necessary for hybridoma activation

  11. Identification of the natural T. gondii antigen GRA6 • Preparation of a plasmid cDNA library with mRNA from T. gondiitachyzoites • Transfection of H-2Ld fibroblasts with cDNA • Incubation with CTgEZ.4 T cell hybridomas • The five most positive had 100% identity to the dense granule protein 6 (GRA6) GRA6: dense granule protein 6; secreted by T. gondii

  12. Hybridoma stimulation • Transfection of H-2Ld fibroblasts with full-length GRA6 cDNA or a c-terminal deletion construct • Incubation with hybridoma • CTgEZ.4 hybridoma were stimulated with full-length but not with mutated GRA6 • the antigenic epitope was located in the deleted residues GRA6: dense granule protein 6; secreted by T. gondii

  13. Hybridomas recognizethe HF10 decapeptide • Systematically testing of all potential peptides •  the decapeptide HPGSVNEFDF (HF10) was recognized by the hybridoma

  14. Fractation by HPLC • Fractation of synthetic HF10 analogs by HPLC • Testing of all fractions for hybridoma activation BMDM: bone marrow–derived macrophages; BMDC: bone marrow–derived dendritic cells HPLC: high-performance liquid chromatography; GRA6: dense granule protein 6

  15. Fractation by HPLC • Fractation of extracts of GRA6-transfected H-2Ld L fibroblasts and T. gondii–infected BMDMs and BMDCs by HPLC • Testing of all fractions for hybridoma activation  HF10 was the naturally processed product of the GRA6 protein presented by H-2Ld BMDM: bone marrow–derived macrophages; BMDC: bone marrow–derived dendritic cells HPLC: high-performance liquid chromatography; GRA6: dense granule protein 6

  16. Monitoring of CD8+ T cells • Orally infection of mice with T. gondii cysts • Incubation of spleen and brain cells with H-2Ld MHC multimers (DimerX) loaded with HF10 or QL9 4 weeks after infection • Staining with PE-coupled α–mouse IgG1

  17. Monitoring of CD8+ T cells • 5% of splenic CD8+ T cells • 24% of CD8+ brain T cells • Only for HF10 but not QL9 •  HF10–H-2Ld was a naturally processed ligand recognized by CD8+ T cells during T. gondii infection.

  18. Monitoring of CD8+ T cells • Speceficity of CD8+ T cells for HF10–H-2Ld was unexpected because the T. gondii genome contains over 8,000 proteinencoding genes • Assesment of the relative frequency of CD8+ T cells specific for HF10 versus other potential antigens among all IFN-γ-producing CD8+ T cells elicited by T. gondii

  19. Monitoring of CD8+ cells • i.p. infection of mice with T. gondii tachyzoites • Splenic CD8+ T cells were stimulated with T. gondii-infected J774 macrophages 4 weeks after infection • 18% produced IFNγ

  20. Monitoring of CD8+ T cells • i.p. infection of mice with T. gondii tachyzoites • Stimulation of the CD8+ T cells with J774 macrophages loaded with the HF10 peptide • 20% produced IFNγ  GRA6-derived HF10 is an immunodominant T. gondii antigen in H-2d mice

  21. Immunization with HF10 • Immunization of B10.D2 H-2d mice with BMDCs pulsed with HF10 or YL9 •  all control mice succumbed to infection within 12 d •  all HF10-immunized mice survived BMDC: bone marrow–derived dendritic cells

  22. Immunization with HF10 • Immunization of C57BL/6 H-2b mice with BMDCs pulsed with HF10 or YL9 •  no protection from T. gondii •  protection from disease was MHC restricted BMDC: bone marrow–derived dendritic cells

  23. Immunization with HF10 • Depletion of CD8+ cells of B10.D2 H-2d mice • Immunization with BMDCs pulsed with HF10 or YL9 • Infection of splenocytes and peritoneal cells with T. gondii (GFP+) •  CD8+ cells were critical for protection •  HF10 was able to elicit a protective CD8+ T cell response during T. gondii infection in H-2d mice BMDC: bone marrow–derived dendritic cells

  24. Processing and generation of HF10–H-2Ld complexes

  25. Processing and generation of HF10–H-2Ld complexes • Treatment of T. gondii infected BMDMs with the proteasome inhibitors epoxomicin or lactacystin • Incubation with hybridoma •  lower CTgEZ.4 hybridoma activation with inhibitor treatment •  Proteasomes were required for the generation of HF10–H-2Ld complexes. BMDM: bone marrow–derived macrophages

  26. Processing and generation of HF10–H-2Ld complexes • Transduction of H-2Ld into TAP-deficient or wild-type C57BL/6 BMDMs • Infection with T. gondii •  TAP-deficient BMDMs failed to stimulate the CTgEZ.4 hybdroma •  TAP transport was essential for presentation of the HF10–H-2Ld complex BMDM: bone marrow–derived macrophages

  27. Processing and generation of HF10–H-2Ld complexes • Infection of ERAAP-heterozygous or ERAAP-deficient BMDMs or BMDCs with T. gondii • Incubation with the CTgEZ.4 hybridoma •  cells from ERAAP-deficient mice were not able to activate the hybridoma BMDM: bone marrow–derived macrophages; BMDC: bone marrow–derived dendritic cells

  28. Processing and generation of HF10–H-2Ld complexes • Incubation of ERAAP-heterozygous or ERAAP-deficient BMDMs or BMDCs presenting HF10 with the hybridoma • Incubation with the CTgEZ.4 hybridoma •  no differences in ERAAP-heterozygous or ERAAP-deficient cells for hybridoma activation BMDM: bone marrow–derived macrophages; BMDC: bone marrow–derived dendritic cells

  29. Processing and generation of HF10–H-2Ld complexes • Extraction of naturally processed peptides from ERAAP-deficient and ERAAP-heterozygous infected BMDMs •  two peaks of antigenic activity • fraction 34 could serve as precursors of HF10 • fraction 32 was barely detected in extracts of ERAAP-deficient cells BMDM: bone marrow–derived macrophages

  30. Processing and generation of HF10–H-2Ld complexes • Measurement of the T. gondii–induced CD8+ T cell responses of ERAAP-deficient mice •  less HF10-specific CD8+ T cells in ERAAP-deficient mice than in ERAAP-heterozygous mice •  ERAAP-deficient APCs can`t generate the HF10–H-2Ld complexes and can`t elicit HF10-specific CD8+ T cell response

  31. Summary • ERAAP-deficient mice are susceptible to T. gondii • GRA6 is the natural T. gondii antigen • HF10 is the naturally processed product of the GRA6 protein presented by H-2Ld • Successfull immunization of mice with HF10 against T. gondii • Protection from disease was MHC restricted • ERAAP-deficient APCs can`t generate the HF10–H-2Ld complexes and can`t elicit HF10-specific CD8+ T cell response

  32. Thank you for your attention

More Related